Abstract G antigen of Rh blood group system is present either along with D and/or C positive red cells. Hence, [serologically anti-G presents with the similar picture as that of multiple antibodies (anti-D ? anti-C). Differentiating them is important as anti-D ? anti-C causes severe hemolytic disease of the fetus and newborn than anti-G. In pregnancies with anti-G alone, alloimmunization due to D antigen could be prevented by prophylactic administration of RhIg. Differentiating between anti-D ? C from anti-G in alloimmunized pregnant mothers becomes essential. Sera from antenatal mothers, whose antibody identification by 11-cell panel gave a pattern for anti-D and anti-C were selected. Extended phenotyping for Rh system was performed for these antenatal cases. Differential adsorption and elution testing using R 2 R 2 cells initially and r'r cells subsequently were performed to distinguish anit-G from anti-D ? anti-C. Antibody titers of these antibodies were determined and their clinical outcome in the newborn was followed. A pattern suggestive of anti D and anti C on antibody identification were observed in six antenatal cases. On further workup 50 % of them confirmed to have anti G. Antibody titers of anti-G and anti-C were lower than that of Anti-D. All newborns were sensitized in vivo and the antibody specificity in them were confirmed with elution studies. The mothers who had only anti-G were subsequently administered with an appropriate dose of RhIg.Differential adsorption and elution studies help in identifying anti-G and distinguishing it from anti-D plus anti-C, thus helping in better patient management.
Introduction
The Rh system is considered the most important blood group system after ABO. Antibodies against Rh antigens are known to cause hemolytic disease of the fetus and newborn (HDFN). Anti C and anti D can cause HDFN however the severity is less in cases with anti-C antibodies [1] . G antigen was first described by Allen and Tippett [2] . The basis of reactivity for G-antigen is Ser103 which is encoded by RHD and by the C allele of RHCE genes [3] . Hence, anti-G appears serologically similar to anti-C plus anti-D. In exceptional cases G antigen can also be found on D-C-RBCs. There are 3 potential antibodies involved here, anti-D, anti-C and anti-G. The pattern of anti-G or anti-D plus anti-C actually have 5 possibilities to unravel: [1] anti-G ? anti-D ? anti-C, [2] anti-G ? anti-D, [3] anti-G ? anti-C, [4] anti-D ? anti-C, or [5] anti-G alone [4] . And their differentiation can be a challenge for immunohematologists.
For transfusion support, it is not necessary to differentiate these components as such patients will receive D and C antigen negative PRBCs, regardless of the antibodies present. However, this differentiation is important in pregnancy as the presence or absence of anti-D warrants administration of RhIg. D-negative mothers with anti-G are potential candidate for Rh prophylaxis in order to prevent possible formation of anti-D. The RhIg prophylaxis can be avoided in mothers who have already developed anti-D. Hence the accurate identification of these antibodies is essential for preventing medical and legal complications [4] .
The purpose of our study was to differentiate anti-G from anti-D and anti-C which can aid in the administration of RhIg prophylaxis to antenatal mothers.
Materials and Methods

Study Participants
This was a cross-sectional study including antenatal mothers in whom antibody screening was requested from October, 2013 to May, 2015. Preset proforma was used to record the obstetric and transfusion details. The study was approved by institutional research and ethics committee.
Laboratory Investigations
Antibody screening was performed using 3 reagent red cell panel (BioRad ID) using column agglutination technique. In positive cases, antibody identification was performed using 11 reagent red cell panels (BioRad ID). The extended phenotyping for Rh antigens was performed in these cases specific, commercially available antisera.
Patient Selection
Serum of antenatal mothers, whose antibody identification gave a pattern for anti-D and anti-C were selected and included for further analysis. Testing was repeated on previously frozen aliquots of serum from the patients during their antenatal checkup.
Differential Adsorption and Elution
Differential adsorption and elution studies using R 2 R 2 cells initially and r'r cells subsequently were performed to exclude the presence of anti-D (Fig. 1) . The first adsorption was performed by incubating equal volumes of enzyme treated R 2 R 2 cells and serum at 37°C for 60 min. The adsorption was performed 2-3 times, in order to obtain a serum that is non-reactive with those RBCs. An eluate was prepared from these adsorbed cells using coldacid elution technique. The eluate was then tested against a panel of RBC which are D?C-and D-C? in antiglobulin phase.
The eluate was then adsorbed with enzyme treated r'r cells, and a second elution was performed on these adsorbed cells using the cold-acid elution technique. The second eluate was again tested against D?C-and D-C? in antiglobulin phase for confirmation. The techniques of differential adsorption and elution studies to identify anti-C plus -D, and -G wereperformed as described by Issitt et al. [5] .
Antibody screening was performed on the adsorbed serum after each step using D?C-and D-C? cells. All reagents and cells used for the differential adsorption and elution were prepared in house.
Antibody Titration
Titration was performed for anti-G, anti-D and anti-C using O-pooled cells, R 2 R 2 cells and r'r cells respectively in saline phase without any enhancement medium. After incubation for 60 min incubation at 37°C, the test was repeated in antiglobulin phase. The end point of titration was reported as the reciprocal of the highest dilution of serum at which 1? agglutination was observed.
Outcome in Newborn
These mothers and their newborns were followed up to note the clinical outcome. The newborn blood group and a direct antiglobulin test were performed to confirm in vivo sensitization. The antibody specificity in the DAT positive cells were confirmed by performing heat elution and testing the eluate with D?C-and D-C? cells. The newborn's hemoglobin, bilirubin and any treatment received were recorded. All the immunohematological tests were carried out as per AABB [6] .
Results
During the study period, 2336 antenatal cases were screened for red cell antibodies, among them 510 were RhD negative. Among the Rh negative pregnancies, six patients (1.2 %) gave a pattern of anti-D ? anti-C on identification panel. Anti-G was confirmed in three cases, while other three had anti D ? C using double adsorption and elution technique (Table 1) . Rh phenotype of all mothers was rr (dce).
In the cases with anti-D ? C, maternal anti-D titers ranged from 16 to 128, while for anti-C, it was between 2 and 4. For anti-G the titers was between 16 and 128.
Details of pregnancies and their outcome are depicted in Table 2 in Table 2 . In case number 6, the patient had received transfusion in childhood during cardic surgery done for correcting the congenital heart defect. And that could be the sensitizing event. The mothers who had only anti-G were subsequently administered with the appropriate dose of Rh Immunoglobulin (RhIg).
Discussion
The G antigen is present on almost all D-positive or C-positive red cells. The differentiation of anti-D? C and anti-G specificities are rarely necessary for routine pretransfusion testing because the transfusion support will be with rr (dce/dce) phenotyped RBC, the most common genotype among all the RhD Negative donors. However, characterizing these antibodies is necessary for an alloimmunized antenatal mother. The clinical outcome in the fetus as well as RhIg prophylaxis is based on the exact identification of these antibodies [7] . The identification of anti-G is a tedious and relatively complex procedure, an area of interest for inquisitive immunohematologist involving challenging workups of double adsorption and elution techniques [8] . In our study, we confirmed three cases of anti-G and another three with anti-D plus anti-C by performing differential adsorption and elution technique. The mean time taken for the full work-up is approximately 6 h. Fatima et al. in their study reported the use of a similar technique for distinguishing anti-D ? C from anti-G [9] . The technique of differential adsorption and elution was initially described by Issitt [5] . Palfi et al. and Shirey et al. had followed the technique using R0 and r' cells while in our study R2R2 and r'r cells were used [4, 8] . We have modified the techniques with respect to the types of cells used and number of adsorption required in order to obtain an IAT negative serum to those RBCs. Our technique is simple and less time consuming. The mean time taken for the full work-up is approximately 6 h. In the present study, the prevalence of Rh D negative cases was high in comparison to the other studies and the prevalence in the general population of our region [10, 11] The reason for the above difference could be that the study is conducted in the tertiary care set-up and the majority of the Rh D negative cases from peripheral hospitals are referred to our center for further management. Higher prevalence of Rh D negative cases (14 %) was also noted in similar study by Al-Ibrahim et al. (14 %) in Saudi Arabia [12] .
From a clinical point of view, identification of anti-C is useful only in giving transfusion support with C antigen negative blood. The clinical significance of anti-G alone still remains controversial [13] . However, the identification of anti-G helped in providing appropriate transfusion support and to prevent Rh D alloimmunization by administering immunoprophylaxis in such cases. We observed that one newborn required both exchange transfusion and phototherapy while the second one could be managed with phototherapy alone.
In our study, mothers, with dual antibody specificity i.e. anti-D ? anti-C showed features of moderate to severe HDFN. Alloimmunization with a combination of three or four antibodies is very rare. A study by Nordvall et al. showed 27 % of cases with multiple antibodies, among which majority (67 %) had anti-D as one among the many antibodies [14] . It's relevant to assess whether only anti-D is present or second antibody are also present with it. A similar study by Howard et al. showed anti-D in combination with another RBC antibody results in a more serious form of HDFN, especially with anti-C [14, 15] . Our observations confirmed that anti-D with anti-C resulted in significant morbidity in newborns.
Conclusion
Antibody identification with extended cell panel is recommended even if the pattern on antibody screen is that of the anti-D and this step will help us to identify the mimicking antibodies like anti-G. The testing method Informed Consent A written informed consent was taken from the antenatal patients before taking part in the study.
